Denali Therapeutics Inc. (NASDAQ:DNLI) appears in 246 institutional 13F filings for the quarter ending December 2025.
| Owner Name | Date | Shares Held | Change (QoQ) | Change (%) | Value (USD) |
|---|---|---|---|---|---|
| BlackRock, Inc. | 31 Mar, 2026 | 13,034,115 | 319,233 | 2.51% | $250,255,006.00 |
| BAILLIE GIFFORD & CO | 31 Mar, 2026 | 12,066,479 | -244,410 | -1.99% | $231,676,397.00 |
| T. Rowe Price Investment Management, Inc. | 31 Mar, 2026 | 8,519,192 | 19,066 | 0.22% | $163,569.00 |
| Temasek Holdings (Private) Ltd | 31 Mar, 2026 | 7,012,974 | 0 | 0.00% | $134,649,101.00 |
| State Street Corp | 31 Mar, 2026 | 6,272,001 | 8,630 | 0.14% | $120,422,419.00 |
| VANGUARD CAPITAL MANAGEMENT LLC | 31 Mar, 2026 | 6,147,957 | 6,147,957 | 0.00% | $118,040,774.00 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 31 Mar, 2026 | 6,120,160 | 6,120,160 | 0.00% | $117,507,072.00 |
| FMR LLC | 31 Mar, 2026 | 4,575,374 | -1,521,837 | -24.96% | $87,847,187.00 |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC | 31 Mar, 2026 | 4,432,314 | -551,412 | -11.06% | $85,100,430.00 |
| Crestline Management, L.P. | 31 Mar, 2026 | 4,421,464 | 1,610,732 | 57.31% | $84,892,108.00 |
| Goldman Sachs Group Inc | 31 Mar, 2026 | 4,407,255 | -3,264,351 | -42.55% | $84,619,301.00 |
| BAKER BROS. ADVISORS LP | 31 Mar, 2026 | 3,731,695 | 0 | 0.00% | $71,648,544.00 |
| GEODE CAPITAL MANAGEMENT, LLC | 31 Mar, 2026 | 3,727,114 | 268,983 | 7.78% | $71,575,052.00 |
| Holocene Advisors, LP | 31 Mar, 2026 | 3,195,429 | 42,695 | 1.35% | $61,352,237.00 |
| ALLIANCEBERNSTEIN L.P. | 31 Mar, 2026 | 2,893,618 | -664,317 | -18.67% | $47,773,633.00 |
| DIMENSIONAL FUND ADVISORS LP | 31 Mar, 2026 | 2,692,175 | 317,872 | 13.39% | $51,686,812.00 |
| UBS Group AG | 31 Mar, 2026 | 2,571,344 | 166,640 | 6.93% | $49,369,805.00 |
| Pictet Asset Management Holding SA | 31 Mar, 2026 | 2,558,865 | 1,229,757 | 92.52% | $48,439,203.00 |
| Capital Research Global Investors | 31 Mar, 2026 | 2,514,588 | -1,214,656 | -32.57% | $48,280,090.00 |
| PRICE T ROWE ASSOCIATES INC /MD/ | 31 Mar, 2026 | 2,464,146 | 2,464,146 | 0.00% | $47,313.00 |